2013 Annual Meeting

To view a session, click PPT Icon to view a PowerPoint slide presentation, Audio Icon to hear the audio, and Video Icon to view a video.

Thursday, February 28, 2013

Clinical Neurostimulation for CNS Diseases: From Basic Mechanisms to Current Therapeutics

Co-Chairs: Shaun Comfort, MD, MBA, Adaptix Clinical Solutions, LLC; Martha Morrell, MD, NeuroPace, Inc

Title Speaker(s) Duration Presentation Audio Video
2 - Introduction to Neurostimulation Shaun Comfort, MD, Adaptix Clinical Solutions, LLC 16min. 45sec. Presentation Audio  
3 - Basic Mechanisms of Neurostimulation Cameron McIntyre, PhD, Cleveland Clinic 28min. 34sec. Presentation Audio  
4 - Neurostimulation for the Treatment of Neurological Disease Jaimie Henderson, MD, Stanford University 43min. 12sec.   Audio  
5 - Intracortical Neural Interfaces for the Restoration of Function Leigh Hochberg, MD, PhD, Massachusetts General Hospital 35 min. 31 sec.   Audio  
6 - The Emergence of Therapeutic Neurostimulation John Reppas, MD, PhD, Neurotechnology Industry Organization 25min. 19sec. Presentation Audio  
7 - Neurostimulation Devices: A Regulatory Perspective Victor Krauthamer, PhD, U.S. Food and Drug Administration 29min. 31sec. Presentation Audio  

Brave New World: Use of the Internet and Social Media to Conduct Clinical Trials

Chair: Nancy Santilli, BSN, MSN, Endo Pharmaceuticals, Inc.

Title Speaker(s) Duration Presentation Audio Video
9 - Introduction to the Session and the Power of Social Media Nancy Santilli, BSN, MSN, Endo Pharmaceuticals, Inc. 9min. 28sec.   Audio  
10 - Social Media and Clinical Trial Recruitment Eileen O’Brien, Siren Interactive 12min. 07 sec. Presentation Audio  
11 - Clinical Trial Enrollment through the New Social Media – Mobil Health Applications Joseph Kim, BS, MBA, Shire Pharmaceuticals 13min. 55sec. Presentation Audio  
12 - Digital Tools for Clinical Development – Virtual Clinical Trials and Beyond Craig Lipset, MPH, Pfizer 22min. 05sec. Presentation Audio  
13 - The FDA Perspective Russell Katz, MD, U.S. Food and Drug Administration 22min. 43sec.   Audio  
14 - Security and Privacy Pitfalls Joanna Napp, Esq., HealthTronics, Inc. 18min. 36sec. Presentation Audio  
15 - From Ground Zero to PreIND in 3.5 Years: How Social Media Helped Us Get Here Sames, Hannah’s Hope Fund, Giant Axonal Neuropathy 12min. 30sec. Presentation Audio  

Assessment of Benefits and Risks: Deciding Whether to Use a New Medication – Patient and Physician Viewpoints

Dinner Session - Co-Chairs: Mitchell Brin, MD, Allergan, Inc.; Kathleen Clarence-Smith, MD, PhD, KM Pharmaceutical Consulting LLC

Title Speaker(s) Duration Presentation Audio Video
17 - Assessment of Benefits and Risks: Deciding Whether to Use a New Medication – Patient and Physician Viewpoints James Simsarian, MD, The Neurology Center of Fairfax, Ltd. 27min. 21sec. Presentation Audio  
18 - Assessment of Benefits and Risks: Deciding Whether to Use a New Medication – Patient and Physician Viewpoints Robin Elliott, MA, Parkinson’s Disease Foundation 25min. 26sec. Presentation Audio  

Friday, March 1, 2013

Barriers in Early Drug Development: Lessons Learned

Co-Chairs: Jesse Cedarbaum, MD, Bristol-Meyers Squibb R&D; Amy Chappell, MD, Eli Lilly & Company; Jill Rasmussen, MD, Psi-Napse

Title Speaker(s) Duration Presentation Audio Video
19 - Of Mice and Men: How Temporal and Other Biological Factors Affect Interpretability of Animal Models Gene Kinney, PhD, Prothena Biosciences 31min. 32sec. Presentation Audio  
20 - Toxicology and Toxicokinetics to Better Predict Therapeutic Index Steve White, PhD, University of Utah 33min. 01sec. Presentation Audio  
21 - Phase 1 Trials: More than Feed and Bleed Ajay Verma, MD, PhD, Biogen Idec 32min. 20sec. Presentation Audio  
22 - Phase 2 Trials: What Can Go Wrong When You Think You’ve Get it Right Amy Chappell, MD, Eli Lilly & Company 30min. Presentation Audio  
23 - A National IRB for Neurodegeneration Studies Ara Khachaturian, PhD, Khachaturian, Radebaugh & Associates 23min. 19sec. Presentation Audio  
24 - The Evolving Mission of NIH/NINDS Rajesh Ranganathan, PhD, NIH/NINDS 30min. 46sec. Presentation Audio  

Saturday, March 2, 2013

New Models for Collaboration: Patients as Drivers and Partners in Neurological Research

Co-Chairs: C. Anthony Altar, PhD, AssureRX Health, Inc.; Robin Elliot, MA, Parkinson's Disease Foundation

Title Speaker(s) Duration Presentation Audio Video
26 - Session Introduction and the Patient Perspective Linda Morgan, MBA, RPh 13 min 58 sec   Audio  
27 - How Patient Collaborations Can Drive Innovation Bray Patrick-Lane, BS, MFS, PFO Foundation 15 min 27 sec Presentation Audio  
28 - Partnering with Patients in Study Protocol Development Amy S. Chappell, M.D., Eli Lilly and Company 10min. 34sec. Presentation Audio  
29 - Rethinking Recruitment and Retention Through Patiens Engagement Petra Kaufmann, MD, NIH/NINDS 14min. 38sec. Presentation Audio  
30 - Integrating Patient Input within the Drug Approval Process Russell Katz, M.D., US Food and Drug Administration 20min. 22sec. Presentation Audio  
31 - Patients as Drivers in Research Prioritization and Funding Robert E. Pacifici, PhD, CHDI Foundation 16min. 44sec Presentation Audio  
New Models for Collaboration: Patient as Drivers and Partners in Neurological Research Panel Panel Discussion 44min. 16sec.   Audio